share_log

華領醫藥-B：股份發行人的證券變動月報表

HUA MEDICINE-B: Monthly Return of Equity Issuer on Movements in Securities

香港交易所 ·  Mar 5 03:30
Summary by Moomoo AI
華領醫藥-B（02552.HK）於2024年2月29日提交了最新的證券變動月報表。報告顯示，公司的法定/註冊股本及已發行股份在2月份均無變動，維持在2,000,000,000股普通股，每股面值0.001美元，法定/註冊股本總額為2,000,000美元。此外，公司的股份期權計劃下，截至2月底，可行使的股份期權數量為53,797,568股，而本月內並無新股份因此發行。公司秘書袁頴欣於2024年3月5日向香港交易及結算所有限公司提交了該報表，並確認所有相關證券的發行均已獲得董事會批准，並符合香港聯合交易所有限公司證券上市規則的要求。
華領醫藥-B（02552.HK）於2024年2月29日提交了最新的證券變動月報表。報告顯示，公司的法定/註冊股本及已發行股份在2月份均無變動，維持在2,000,000,000股普通股，每股面值0.001美元，法定/註冊股本總額為2,000,000美元。此外，公司的股份期權計劃下，截至2月底，可行使的股份期權數量為53,797,568股，而本月內並無新股份因此發行。公司秘書袁頴欣於2024年3月5日向香港交易及結算所有限公司提交了該報表，並確認所有相關證券的發行均已獲得董事會批准，並符合香港聯合交易所有限公司證券上市規則的要求。
Hualien Pharmaceutical-B (02552.HK) filed its latest Securities Monthly Change Report on February 29, 2024. THE REPORT SHOWS THAT THE COMPANY'S STATUTORY/REGISTERED SHARE CAPITAL AND ISSUED SHARES REMAINED UNCHANGED IN FEBRUARY, AT 2,000,000,000 SHARES OF ORDINARY SHARES WITH A FACE VALUE OF $0.001 PER SHARE AND A TOTAL STATUTORY/REGISTERED SHARE CAPITAL OF $2,000,000. In addition, under the Company's stock option plan, the number of share options available at the end of February was 53,797,568 shares, and therefore no new shares were issued during the month. COMPANY SECRETARY YUAN WING-XIN SUBMITTED THE REPORT TO HONG KONG TRADING AND SETTLEMENT LIMITED ON 5 MARCH 2024, CONFIRMING THAT ALL RELEVANT SECURITIES WERE APPROVED BY THE BOARD OF DIRECTORS AND COMPLIED WITH THE LISTING RULES OF THE HONG KONG STOCK EXCHANGE LIMITED.
Hualien Pharmaceutical-B (02552.HK) filed its latest Securities Monthly Change Report on February 29, 2024. THE REPORT SHOWS THAT THE COMPANY'S STATUTORY/REGISTERED SHARE CAPITAL AND ISSUED SHARES REMAINED UNCHANGED IN FEBRUARY, AT 2,000,000,000 SHARES OF ORDINARY SHARES WITH A FACE VALUE OF $0.001 PER SHARE AND A TOTAL STATUTORY/REGISTERED SHARE CAPITAL OF $2,000,000. In addition, under the Company's stock option plan, the number of share options available at the end of February was 53,797,568 shares, and therefore no new shares were issued during the month. COMPANY SECRETARY YUAN WING-XIN SUBMITTED THE REPORT TO HONG KONG TRADING AND SETTLEMENT LIMITED ON 5 MARCH 2024, CONFIRMING THAT ALL RELEVANT SECURITIES WERE APPROVED BY THE BOARD OF DIRECTORS AND COMPLIED WITH THE LISTING RULES OF THE HONG KONG STOCK EXCHANGE LIMITED.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more